NAPLES, Fla., - Catalyst OrthoScience Inc. (“Catalyst”), a private medical technology leader focused on shoulder arthroplasty, the fastest growing segment in the orthopedics market, announces it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) and the first surgeries have been successfully performed for the Catalyst Fracture…
Read More
® indicates U.S. trademark registration. All trademarks and/or images are the property of their respective owners or holders.
© 2024 Catalyst OrthoScience Inc. All rights reserved.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.